Compound traditional Chinese medicine composition for treating chronic atrophic gastritis and application
A technology of atrophic gastritis and compound traditional Chinese medicine, applied in the field of pharmaceutical research and development, can solve problems such as inability to cure radically and drug side effects, and achieve the effects of improving the body's immunity, preventing precancerous lesions, and promoting the secretion of gastric juice
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0043] Example 1: Curative Effect Observation of Compound Chinese Medicine Composition in Treating Qi Deficiency and Blood Stasis Type Chronic Atrophic Gastritis
[0044] 1. Research object:
[0045] 1.1 Case source:
[0046]All case data come from January 2017-December 2021, patients with chronic atrophic gastritis of Qi deficiency and blood stasis who met the inclusion and exclusion criteria in the Digestive Endoscopy Clinic of Jiangsu Provincial Hospital of Traditional Chinese Medicine. This retrospective study took January 2019 as the boundary. Before January 2019, it was the old prescription of Meiqing Decoction, and after January 2019, it was the improved prescription of Meiqing Decoction (that is, the formula of the compound Chinese medicine composition of the present invention). A total of 148 patients were included, including 71 males, aged 26-77 years, (51±12.73) years old; 77 females, aged 31-78 years old, aged (43.5±12.02) years old.
[0047] 1.2 Diagnostic crite...
Embodiment 2
[0116] Embodiment 2: The compound Chinese medicine composition of the present invention treats the animal experiment of rat chronic atrophic gastritis 1, material and method
[0117] (1) Experimental animals and grouping: 48 male SD rats of SPF grade 8 weeks old (Speyford (Beijing) Biotechnology Co., Ltd., license number: SCXK (Beijing) 2016-0002), weighing 210-250g, divided into There are 6 groups of 8 animals in each group. The groups are: A. Blank control group, B. Pathological model group, C. High-dose Meiqing Decoction old prescription group, D. Low-dose Meiqing Decoction improved prescription group, E. Medium-dose Meiqing Decoction improved prescription group, F. High-dose Meiqing decoction modified prescription group. Animals were fed in the Animal Experiment Center of Jiangsu Provincial Hospital of Traditional Chinese Medicine (Affiliated Hospital of Nanjing University of Traditional Chinese Medicine), with a laboratory temperature of 18-22° C. and a relative humidity...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com